✦ LIBER ✦

Risk factors for early recurrences after conventional- or high-dose adjuvant chemotherapy in breast cancer patients with extensive lymph node involvement

✍ Scribed by I.F Faneyte; J.L Peterse; H Van Tinteren; C Pronk; E.G.E De Vries; S Rodenhuis; M.J van de Vijver

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High dose chemotherapy as adjuvant treat

✍ Eiichi Shiba; Kenji Akazawa; Seung Jin Kim; Tetsuya Taguchi; Fumine Tsukamoto; H 📂 Article 📅 2000 🏛 Springer Japan 🌐 English ⚖ 419 KB

High-dose chemotherapy with autologous b

✍ Lalisang, R I; Hupperets, P S G J; ten Haaft, M A; Jansen, R L H; Schouten, H C 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 52 KB

High-dose chemotherapy with autologous p

✍ Bearman, S I; Overmoyer, B A; Bolwell, B J; Taylor, C W; Shpall, E J; Cagnoni, P 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 98 KB

351 - Adjuvant chemotherapy with ac vers

✍ P. Fumoleau; F. Chauvln; M. Namer; R. Bugat; M. Tublana-Hulin; J.P. Guastalla; T 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 218 KB